共 50 条
- [21] The effect of Oncotype DX® Recurrence Score on treatment recommendations for geriatric patients with early stage hormone receptor positive breast cancerCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S33 - S34Loftus, L.Acs, G.Kiluk, J.Laronga, C.Lee, M. C.Soliman, H.Boughey, J. C.Acs, P.Gordon, L.Sokol, G.
- [22] Prediction of Oncotype DX Recurrence Score by Evaluating the Peritumoral Tumor Budding in Early-stage Breast CarcinomaANTICANCER RESEARCH, 2023, 43 (12) : 5563 - 5571Chu, JinahDo, JeongeunDo, Sung-ImKim, Hyun-Soo
- [23] Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score AssayEJSO, 2017, 43 (05): : 921 - 930Curtit, E.Mansi, L.Maisonnette-Escot, Y.Sautiere, J. -L.Pivot, X.
- [24] Evaluation of Oncotype DX testing and subsequent patterns of care in patients (pts) with early-stage breast cancer (ESBC).JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Fitzgerald, MeghanHassell, RobertHaislip, SallyGilmore, James W.Richardson, SteveCooper, JosephSzabo, StephenFeinberg, Bruce A.
- [25] Comparison of PREDICT Score to Oncotype Dx Score in Early Invasive Breast CancerBRITISH JOURNAL OF SURGERY, 2021, 108Frixou, M.Makaranka, S.Urquhart, G.Elsberger, B.
- [26] Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancernpj Breast Cancer, 9Luca LicataGiulia VialeMario GiulianoGiuseppe CuriglianoMariana Chavez-MacGregorJulia FoldiOluchi OkeJoseph CollinsLucia Del MastroFabio PuglisiFilippo MontemurroClaudio VernieriLorenzo GerratanaSara GiordanoAlessia RognoneLorenzo SicaOreste Davide GentiliniStefano CascinuLajos PusztaiAntonio GiordanoCarmen CriscitielloGiampaolo Bianchini
- [27] Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerNPJ BREAST CANCER, 2023, 9 (01)Licata, LucaViale, GiuliaGiuliano, MarioCurigliano, GiuseppeChavez-MacGregor, MarianaFoldi, JuliaOke, OluchiCollins, JosephDel Mastro, LuciaPuglisi, FabioMontemurro, FilippoVernieri, ClaudioGerratana, LorenzoGiordano, SaraRognone, AlessiaSica, LorenzoGentilini, Oreste DavideCascinu, StefanoPusztai, LajosGiordano, AntonioCriscitiello, CarmenBianchini, Giampaolo
- [28] OUR FIRST EXPERIENCE OF ONCOTYPE DX IN EARLY BREAST CANCERANNALS OF ONCOLOGY, 2011, 22 : 46 - 46Khawaja, S.Sharaiha, Y.Pitcher, S.Whelan, S.Brinkworth, E.Pudney, D.Moe, M.Rolles, M.Bertelli, G.Holt, S.
- [29] Oncotype DX testing in early-stage node-positive breast cancer and impact on chemotherapy use at a comprehensive cancer center.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Losk, KatyaFreedman, Rachel A.Mittendorf, Elizabeth A.Tan-Wasielewski, ZhenyingTrippa, LorenzoKing, Tari A.
- [30] Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of TurkeyFRONTIERS IN ONCOLOGY, 2023, 13Unal, CaglarOzmen, TolgaOrdu, CetinPilanci, Kezban NurIlgun, Ahmet SerkanGokmen, ErhanAlmuradova, ElvinaOzdogan, MustafaGuler, NilueferUras, CihanKara, HalilDemircan, OrhanIsik, SelverAlco, GulSaip, PinarAydin, EsraDuymaz, TomrisCelebi, FilizYararbas, KanaySoybir, GurselOzmen, Vahit